36 Liraglutide seems to offer a body-weight loss of 46 kg compared to placebo, 37 while the protective effect on cardiovascular outcomes (lower rates of myocardial infarction, stroke and death) is notable, 38 as is the lower rates of diabetes nephropathy development and progression
Should someone with MCAS or histamine intolerance avoid peptide therapy
Rodent, goat, and petri-dish results establish biological plausibility and guide further research, but they routinely fail to translate to humans
When to Expect Results Based on research and anecdotal reports: Week 1-2: Increased energy and better sleep quality Week 3-4: Noticeable reduction in abdominal fat, improved muscle definition Week 6-8: Significant fat loss, better insulin sensitivity (if measured) Week 8-12: Maximum effects plateau, consider cycling off Cycling Recommendations Most protocols recommend: 8 to 12 weeks on 4 to 8 weeks off Reassess and repeat if needed Cycling allows your body to maintain sensitivity to the compound and prevents potential long-term adaptations
Yes, but with caveats
However, it is worth noting that capsule null strains or strains with mutations impeding capsule expression are more frequently clustered in carriage-associated ccs, such as cc198, cc1136, and cc53 (Moreno et al., 2015